half life of glp 1 agonists Another milestone in the evolution GLP-1-based diabetes therapies Glucagon-like peptide 1 (GLP-1) -

Effect of glucagon on ischemic heart disease and its risk factors: a Mendelian randomization study

Weight regain following GLP-1 discontinuation occurs gradually but consistently in most patients

Thus, the organism could be quite appealing for direct oral delivery in its intact cellular form, if it could be engineered to synthesize a GLP-1 molecule in sufficient quantities

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

But in an IBD gut, where the mucus layer is already compromised and inflammation is already elevated, adding a mucus-consuming bacterium can exacerbate barrier damage